Latest Mitral valve replacement Stories
NEW ORLEANS, Aug. 27 /PRNewswire/ -- On Tuesday, August 11, 2009, an 82-year old New Orleans resident with severe aortic stenosis successfully had a heart valve replaced at Ochsner Medical Center using the same technique as angioplasty, a far cry from the traditional open heart procedure.
MENLO PARK, Calif., Aug. 24 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, today announced treatment of the first group of patients with the MitraClip(R) system at the Karolinska University Hospital in Solna, Stockholm, Sweden.
LOS ANGELES, July 27 /PRNewswire/ -- The California Cardiothoracic Surgery Center specializes in cardiothoracic surgery including mitral valve replacement. Fatigue shortness of breath and coughing might not seem like serious symptoms.
Tour Includes Demonstration of Robotically Assisted Heart Valve RepairCLEVELAND, July 23 /PRNewswire-USNewswire/ -- Today, President Barack Obama visited Cleveland Clinic for an inside look at its model of healthcare, how it utilizes health information technology, and a demonstration in the operating room.
Studies Show a Sunny Outlook is Good for Health, Longer LifeROCHESTER, Minn., July 22 /PRNewswire-USNewswire/ -- Here are highlights from the July issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee.
A new nonsurgical technique to repair leaking mitral valves in heart failure patients was safe in a study reported in Circulation: Cardiovascular Interventions.
Use of the MitraClip(R) Therapy Continues to Expand in Europe MENLO PARK, Calif., May 14 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first 100 patients have been treated with the MitraClip(R) system in Europe.
European Trials Commencing for Injectable Biopolymer to Repair Weakened Heart Wall LAGUNA HILLS, Calif., April 14 /PRNewswire/ -- Symphony Medical, Inc., a developer of novel biopolymer therapies to cardiac abnormalities, announced today that its patented flagship technology, Algisyl-LVR(R), was used on a human for the first time, successfully treating a 50-year-old male who was suffering from chronic heart failure.
European Post Market Observational Study Intended to Collect Data to Demonstrate the Clinical and Health Economic Benefits of the MitraClip(R) Therapy for Patients with Mitral Regurgitation MENLO PARK, Calif., April 6 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today the first enrollment in the ACCESS-Europe study, a post-market observational study of the MitraClip(R) therapy in Europe.